Hubei Fuxing Science and Technology Co.,Ltd Logo

Hubei Fuxing Science and Technology Co.,Ltd

000926.SZ

(1.8)
Stock Price

1,88 CNY

0.57% ROA

1.88% ROE

18.19x PER

Market Cap.

3.575.420.576,00 CNY

55.4% DER

0.74% Yield

2.04% NPM

Hubei Fuxing Science and Technology Co.,Ltd Stock Analysis

Hubei Fuxing Science and Technology Co.,Ltd Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Hubei Fuxing Science and Technology Co.,Ltd Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.37x), the stock offers substantial upside potential at a bargain price.

2 ROE

ROE in an average range (1.88%) suggests satisfactory profitability and decent utilization of shareholders' equity.

3 ROA

The stock's ROA (0.57%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

4 DER

The stock maintains a fair debt to equity ratio (55%), indicating a reasonable balance between the money it owes and the ownership it possesses.

5 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

6 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (114) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

7 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

9 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

10 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

11 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

Hubei Fuxing Science and Technology Co.,Ltd Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Hubei Fuxing Science and Technology Co.,Ltd Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Hubei Fuxing Science and Technology Co.,Ltd Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Hubei Fuxing Science and Technology Co.,Ltd Revenue
Year Revenue Growth
1996 237.881.489
1997 300.287.082 20.78%
1998 384.422.715 21.89%
1999 358.999.872 -7.08%
2000 389.220.781 7.76%
2001 425.590.395 8.55%
2002 436.138.019 2.42%
2003 855.768.017 49.04%
2004 1.419.722.274 39.72%
2005 2.082.515.320 31.83%
2006 2.451.680.527 15.06%
2007 3.337.607.772 26.54%
2008 3.201.425.893 -4.25%
2009 4.097.329.641 21.87%
2010 5.625.510.470 27.17%
2011 4.760.583.882 -18.17%
2012 6.244.510.925 23.76%
2013 7.662.682.407 18.51%
2014 6.686.444.502 -14.6%
2015 8.028.869.707 16.72%
2016 10.484.662.040 23.42%
2017 11.658.511.149 10.07%
2018 10.735.228.263 -8.6%
2019 9.566.158.361 -12.22%
2020 7.501.140.799 -27.53%
2021 12.543.502.446 40.2%
2022 15.142.322.203 17.16%
2023 4.125.104.254 -267.08%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Hubei Fuxing Science and Technology Co.,Ltd Research and Development Expenses
Year Research and Development Expenses Growth
1996 0
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 12.633.747 100%
2011 13.056.127 3.24%
2012 14.742.874 11.44%
2013 14.340.532 -2.81%
2014 14.770.153 2.91%
2015 8.400.365 -75.83%
2016 8.902.558 5.64%
2017 8.972.267 0.78%
2018 8.989.126 0.19%
2019 48.218.102 81.36%
2020 38.483.413 -25.3%
2021 52.064.931 26.09%
2022 34.595.622 -50.5%
2023 35.855.245 3.51%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Hubei Fuxing Science and Technology Co.,Ltd General and Administrative Expenses
Year General and Administrative Expenses Growth
1996 7.580.218
1997 7.238.785 -4.72%
1998 11.930.332 39.32%
1999 12.283.796 2.88%
2000 11.404.019 -7.71%
2001 13.862.104 17.73%
2002 16.938.557 18.16%
2003 22.497.649 24.71%
2004 30.708.934 26.74%
2005 46.832.170 34.43%
2006 51.619.537 9.27%
2007 75.034.855 31.21%
2008 94.618.266 20.7%
2009 98.293.420 3.74%
2010 48.978.522 -100.69%
2011 41.387.638 -18.34%
2012 37.578.016 -10.14%
2013 46.156.920 18.59%
2014 67.174.605 31.29%
2015 124.587.759 46.08%
2016 140.158.009 11.11%
2017 139.244.818 -0.66%
2018 203.158.320 31.46%
2019 219.826.620 7.58%
2020 163.908.904 -34.12%
2021 139.431.982 -17.55%
2022 170.369.239 18.16%
2023 484.042.405 64.8%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Hubei Fuxing Science and Technology Co.,Ltd EBITDA
Year EBITDA Growth
1996 49.766.863
1997 67.486.674 26.26%
1998 103.812.035 34.99%
1999 94.175.474 -10.23%
2000 123.252.191 23.59%
2001 129.310.000 4.68%
2002 117.190.501 -10.34%
2003 202.398.208 42.1%
2004 330.195.376 38.7%
2005 374.485.539 11.83%
2006 542.364.340 30.95%
2007 705.924.696 23.17%
2008 660.796.252 -6.83%
2009 690.204.606 4.26%
2010 970.970.800 28.92%
2011 1.036.472.210 6.32%
2012 1.142.477.651 9.28%
2013 1.320.127.571 13.46%
2014 1.559.194.638 15.33%
2015 1.458.369.642 -6.91%
2016 1.718.395.028 15.13%
2017 2.363.882.013 27.31%
2018 2.321.016.219 -1.85%
2019 1.685.263.641 -37.72%
2020 1.036.560.931 -62.58%
2021 1.447.509.975 28.39%
2022 1.510.728.379 4.18%
2023 717.215.733 -110.64%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Hubei Fuxing Science and Technology Co.,Ltd Gross Profit
Year Gross Profit Growth
1996 64.107.841
1997 83.834.754 23.53%
1998 114.876.410 27.02%
1999 105.741.082 -8.64%
2000 124.829.928 15.29%
2001 134.029.817 6.86%
2002 102.821.488 -30.35%
2003 249.720.586 58.83%
2004 419.019.978 40.4%
2005 495.347.821 15.41%
2006 707.267.204 29.96%
2007 947.641.209 25.37%
2008 953.106.767 0.57%
2009 1.014.875.693 6.09%
2010 1.474.302.355 31.16%
2011 1.509.917.309 2.36%
2012 1.753.885.583 13.91%
2013 1.989.829.689 11.86%
2014 1.246.660.118 -59.61%
2015 1.996.542.124 37.56%
2016 2.344.940.657 14.86%
2017 3.099.670.463 24.35%
2018 3.274.678.155 5.34%
2019 2.359.420.295 -38.79%
2020 1.559.024.947 -51.34%
2021 2.437.946.400 36.05%
2022 3.125.188.175 21.99%
2023 895.247.426 -249.09%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Hubei Fuxing Science and Technology Co.,Ltd Net Profit
Year Net Profit Growth
1996 32.118.823
1997 45.715.302 29.74%
1998 56.973.242 19.76%
1999 57.484.992 0.89%
2000 82.993.161 30.74%
2001 83.576.693 0.7%
2002 45.853.590 -82.27%
2003 87.046.983 47.32%
2004 159.029.526 45.26%
2005 163.381.045 2.66%
2006 258.192.690 36.72%
2007 317.489.256 18.68%
2008 330.369.143 3.9%
2009 336.377.732 1.79%
2010 500.795.840 32.83%
2011 522.521.674 4.16%
2012 611.170.360 14.5%
2013 671.794.600 9.02%
2014 704.869.572 4.69%
2015 468.870.301 -50.33%
2016 581.056.210 19.31%
2017 845.355.416 31.26%
2018 1.134.510.904 25.49%
2019 597.631.326 -89.83%
2020 306.395.993 -95.05%
2021 356.349.452 14.02%
2022 141.379.748 -152.05%
2023 23.994.141 -489.23%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Hubei Fuxing Science and Technology Co.,Ltd Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1996 0
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 1 100%
2007 1 0%
2008 1 0%
2009 0 0%
2010 1 0%
2011 1 0%
2012 1 0%
2013 1 0%
2014 1 100%
2015 1 0%
2016 1 0%
2017 1 0%
2018 1 100%
2019 1 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Hubei Fuxing Science and Technology Co.,Ltd Free Cashflow
Year Free Cashflow Growth
1998 58.285.871
1999 6.501.122 -796.55%
2000 -165.554.856 103.93%
2001 -137.500.735 -20.4%
2002 -342.493.705 59.85%
2003 -443.333.781 22.75%
2004 27.849.338 1691.9%
2005 -180.789.529 115.4%
2006 -266.051.204 32.05%
2007 -118.379.480 -124.74%
2008 -159.650.907 25.85%
2009 -1.011.096.751 84.21%
2010 -2.655.732.792 61.93%
2011 -2.121.278.161 -25.19%
2012 685.253.009 409.56%
2013 -33.700.693 2133.35%
2014 -1.641.941.770 97.95%
2015 29.967.337 5579.1%
2016 2.330.206.276 98.71%
2017 24.163.990 -9543.3%
2018 38.673.485 37.52%
2019 6.482.151.771 99.4%
2020 5.325.974.572 -21.71%
2021 5.032.229.089 -5.84%
2022 2.188.614.173 -129.93%
2023 910.851.881 -140.28%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Hubei Fuxing Science and Technology Co.,Ltd Operating Cashflow
Year Operating Cashflow Growth
1998 75.407.896
1999 50.310.177 -49.89%
2000 57.598.904 12.65%
2001 -33.880.182 270.01%
2002 -206.400.300 83.59%
2003 -253.605.456 18.61%
2004 345.074.555 173.49%
2005 184.998.160 -86.53%
2006 -138.765.204 233.32%
2007 28.968.227 579.03%
2008 19.423.113 -49.14%
2009 -554.019.408 103.51%
2010 -2.139.359.983 74.1%
2011 -1.745.266.421 -22.58%
2012 769.341.038 326.85%
2013 74.901.964 -927.13%
2014 -1.520.647.918 104.93%
2015 43.518.625 3594.25%
2016 2.343.512.379 98.14%
2017 131.385.590 -1683.69%
2018 93.482.620 -40.55%
2019 6.538.748.331 98.57%
2020 5.362.661.281 -21.93%
2021 5.078.956.277 -5.59%
2022 2.211.029.850 -129.71%
2023 924.134.917 -139.25%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Hubei Fuxing Science and Technology Co.,Ltd Capital Expenditure
Year Capital Expenditure Growth
1998 17.122.025
1999 43.809.054 60.92%
2000 223.153.760 80.37%
2001 103.620.554 -115.36%
2002 136.093.405 23.86%
2003 189.728.325 28.27%
2004 317.225.217 40.19%
2005 365.787.689 13.28%
2006 127.286.000 -187.37%
2007 147.347.707 13.62%
2008 179.074.020 17.72%
2009 457.077.343 60.82%
2010 516.372.809 11.48%
2011 376.011.740 -37.33%
2012 84.088.029 -347.16%
2013 108.602.657 22.57%
2014 121.293.853 10.46%
2015 13.551.288 -795.07%
2016 13.306.103 -1.84%
2017 107.221.600 87.59%
2018 54.809.135 -95.63%
2019 56.596.560 3.16%
2020 36.686.709 -54.27%
2021 46.727.188 21.49%
2022 22.415.677 -108.46%
2023 13.283.036 -68.75%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Hubei Fuxing Science and Technology Co.,Ltd Equity
Year Equity Growth
1996 185.236.869
1997 230.952.171 19.79%
1998 287.925.412 19.79%
1999 556.319.771 48.24%
2000 605.976.057 8.19%
2001 647.633.576 6.43%
2002 690.560.761 6.22%
2003 777.383.543 11.17%
2004 909.743.569 14.55%
2005 1.111.220.429 18.13%
2006 1.777.359.821 37.48%
2007 2.104.800.589 15.56%
2008 3.575.875.702 41.14%
2009 3.957.155.545 9.64%
2010 4.713.199.235 16.04%
2011 5.635.720.909 16.37%
2012 5.763.641.391 2.22%
2013 6.775.914.062 14.94%
2014 6.932.115.311 2.25%
2015 9.014.975.933 23.1%
2016 9.678.934.907 6.86%
2017 10.272.625.091 5.78%
2018 12.078.962.908 14.95%
2019 12.368.750.106 2.34%
2020 12.283.046.438 -0.7%
2021 12.417.914.308 1.09%
2022 12.363.532.375 -0.44%
2023 12.366.268.512 0.02%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Hubei Fuxing Science and Technology Co.,Ltd Assets
Year Assets Growth
1996 347.952.978
1997 406.718.405 14.45%
1998 546.675.100 25.6%
1999 774.896.574 29.45%
2000 871.882.598 11.12%
2001 1.125.642.251 22.54%
2002 1.534.255.613 26.63%
2003 2.319.191.538 33.85%
2004 3.081.988.184 24.75%
2005 3.464.904.734 11.05%
2006 4.690.121.918 26.12%
2007 5.866.184.045 20.05%
2008 7.216.118.396 18.71%
2009 9.445.297.606 23.6%
2010 15.528.053.352 39.17%
2011 21.910.226.772 29.13%
2012 25.497.463.988 14.07%
2013 27.110.988.725 5.95%
2014 28.778.766.698 5.8%
2015 39.395.203.061 26.95%
2016 45.537.503.736 13.49%
2017 49.002.393.410 7.07%
2018 47.479.062.243 -3.21%
2019 51.077.667.216 7.05%
2020 52.454.852.157 2.63%
2021 48.548.279.242 -8.05%
2022 38.275.030.779 -26.84%
2023 37.028.499.425 -3.37%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Hubei Fuxing Science and Technology Co.,Ltd Liabilities
Year Liabilities Growth
1996 162.716.109
1997 175.766.234 7.42%
1998 249.281.489 29.49%
1999 208.005.636 -19.84%
2000 265.906.541 21.77%
2001 469.988.414 43.42%
2002 834.518.939 43.68%
2003 1.529.843.128 45.45%
2004 2.157.316.614 29.09%
2005 2.328.958.367 7.37%
2006 2.878.347.338 19.09%
2007 3.703.720.158 22.28%
2008 3.630.243.072 -2.02%
2009 5.444.072.440 33.32%
2010 10.162.850.169 46.43%
2011 14.430.017.925 29.57%
2012 18.078.363.366 20.18%
2013 18.209.509.754 0.72%
2014 20.738.368.184 12.19%
2015 28.603.077.295 27.5%
2016 33.488.911.954 14.59%
2017 37.108.250.321 9.75%
2018 35.400.099.334 -4.83%
2019 38.708.917.110 8.55%
2020 40.171.805.719 3.64%
2021 36.130.364.934 -11.19%
2022 25.911.498.404 -39.44%
2023 24.662.230.913 -5.07%

Hubei Fuxing Science and Technology Co.,Ltd Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
10.94
Net Income per Share
0.22
Price to Earning Ratio
18.19x
Price To Sales Ratio
0.34x
POCF Ratio
5.59
PFCF Ratio
5.28
Price to Book Ratio
0.34
EV to Sales
0.72
EV Over EBITDA
5.39
EV to Operating CashFlow
10.81
EV to FreeCashFlow
11.03
Earnings Yield
0.05
FreeCashFlow Yield
0.19
Market Cap
3,58 Bil.
Enterprise Value
7,46 Bil.
Graham Number
7.73
Graham NetNet
-15.62

Income Statement Metrics

Net Income per Share
0.22
Income Quality
3.99
ROE
0.02
Return On Assets
0.01
Return On Capital Employed
0.04
Net Income per EBT
0.3
EBT Per Ebit
0.98
Ebit per Revenue
0.07
Effective Tax Rate
0.76

Margins

Sales, General, & Administrative to Revenue
0.02
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.27
Operating Profit Margin
0.07
Pretax Profit Margin
0.07
Net Profit Margin
0.02

Dividends

Dividend Yield
0.01
Dividend Yield %
0.74
Payout Ratio
3.86
Dividend Per Share
0.03

Operating Metrics

Operating Cashflow per Share
0.73
Free CashFlow per Share
0.71
Capex to Operating CashFlow
-0.02
Capex to Revenue
-0
Capex to Depreciation
0
Return on Invested Capital
0.01
Return on Tangible Assets
0.01
Days Sales Outstanding
175.84
Days Payables Outstanding
159.37
Days of Inventory on Hand
992.31
Receivables Turnover
2.08
Payables Turnover
2.29
Inventory Turnover
0.37
Capex per Share
-0.01

Balance Sheet

Cash per Share
-4,44
Book Value per Share
11,89
Tangible Book Value per Share
12.97
Shareholders Equity per Share
11.89
Interest Debt per Share
6.94
Debt to Equity
0.55
Debt to Assets
0.17
Net Debt to EBITDA
2.81
Current Ratio
1.56
Tangible Asset Value
12,32 Bil.
Net Current Asset Value
4,07 Bil.
Invested Capital
0.55
Working Capital
10,34 Bil.
Intangibles to Total Assets
0
Average Receivables
5,03 Bil.
Average Payables
3,14 Bil.
Average Inventory
20684480465.9
Debt to Market Cap
1.75

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Hubei Fuxing Science and Technology Co.,Ltd Dividends
Year Dividends Growth
1999 0
2001 0 0%
2002 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2023 0 0%

Hubei Fuxing Science and Technology Co.,Ltd Profile

About Hubei Fuxing Science and Technology Co.,Ltd

Hubei Fuxing Science and Technology Co.,Ltd. produces steel products in China. The company offers radial tire steel cords, tires steel products, PC steel hinges, steel wire ropes, prestressed PC steel strands, tire wires, and other products. The company also exports its products. Hubei Fuxing Science and Technology Co.,Ltd. was founded in 1993 and is based in Hanchuan, China.

CEO
Mr. Dong Xing Feng
Employee
2.547
Address
No. 1 Fuxing Street
Hanchuan, 431608

Hubei Fuxing Science and Technology Co.,Ltd Executives & BODs

Hubei Fuxing Science and Technology Co.,Ltd Executives & BODs
# Name Age
1 Mr. Yong Chao Xiao
Board Secretary & Additional Director
70
2 Ms. Le Xiang
Deputy General Manager
70
3 Mr. Dong Xing Feng
GM & Director
70
4 Mr. Jun Xiu Feng
Chief Financial Officer & Director
70

Hubei Fuxing Science and Technology Co.,Ltd Competitors